DOSSIER · 13F Holders · Q1 2026Healthcare · Pharmaceutical Preparations
DAWN
DAY ONE BIOPHARMACEUTICALS I
30 institutions still hold DAY ONE BIOPHARMACEUTICALS I as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 23954D109·Pharmaceutical Preparations·30 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
30 institutions reported DAWN in Q1 2026. GLAZER CAPITAL, LLC leads at 37.5% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 2
10 more holders available. Log in →